Co-Diagnostics, Inc. (CODX) › Capital ExpendituresCo-Diagnostics, Inc. (CODX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $12.2K2017: $129.3K2018: $41.3K2019: $113.2K2020: $774.4K2021: $669.5K2022: $1.43M2023: $1.37M2024: $748.4K2025: $700.0K$700.0K2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$700.0K-6.5%2024$748.4K-45.2%2023$1.37M-4.4%2022$1.43M+113.2%2021$669.5K-13.6%2020$774.4K+583.8%2019$113.2K+174.0%2018$41.3K-68.0%2017$129.3K+956.3%2016$12.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share